A phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivors
Jennifer S. Gewandter(University of Rochester), Gary R. Morrow(University of Rochester Medical Center), Judith O. Hopkins(Novant Health), Charles E. Heckler(University of Rochester Medicine), Julie L. Ryan(University of Rochester Medicine), Patrick J. Flynn(American Society of Clinical Oncology), Jeffrey J. Kirshner(American Society of Clinical Oncology), Supriya G. Mohile(University of Rochester Medical Center)
Cited by 126
Related Papers
American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer
|Journal of Clinical Oncology|2004|1.5k
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue
|JAMA Oncology|2017|913
Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology*
|Journal of Clinical Oncology|2001|819
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
|Journal of Clinical Oncology|1999|670
Colorectal Cancer Surveillance: 2005 Update of an American Society of Clinical Oncology Practice Guideline
|Journal of Clinical Oncology|2005|565